Rigel Pharmaceuticals Inc Dividends
The next dividend date for Rigel Pharmaceuticals Inc has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for Rigel Pharmaceuticals Inc (RIGL)
More About Rigel Pharmaceuticals Inc
Rigel Pharmaceuticals, Inc., a biotechnology company, engages in discovering, developing, and providing therapies that enhance the lives of patients with hematologic disorders and cancer. The company's commercialized products include Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia; Rezlidhia, a non-intensive monotherapy to treat adult patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test; and GAVRETO, a once daily, small molecule, oral, kinase inhibitor for the treatment of adult patients with metastatic rearranged during transfection (RET) fusion-positive non-small cell lung cancer (NSCLC), as well as to treat adult and pediatric patients twelve years of age and older with advanced or metastatic RET fusion-positive thyroid cancer. It also develops R289, an oral interleukin receptor-associated kinases 1 and 4 (IRAK1/4) inhibitor for the treatment of hematology-oncology, autoimmune, and inflammatory diseases, as well as to treat lower-risk myelodysplastic syndrome. In addition, the company has product candidates in clinical development with partners BerGenBio ASA, Eli Lilly and Company, and Daiichi Sankyo. It has strategic development collaboration with The University of Texas MD Anderson Cancer Center for the development of Olutasidenib in AML and other hematologic cancers with IDH1mutations, as well as with collaborative network for neuro-oncology clinical trials to evaluate Olutasidenib in combination with temozolomide in patients with high-grade glioma harboring an IDH1 mutation. Rigel Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in South San Francisco, California.
Owning Rigel Pharmaceuticals Inc Stock on the Dividend Date
If you own Rigel Pharmaceuticals Inc stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of Rigel Pharmaceuticals Inc stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Rigel Pharmaceuticals Inc stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying Rigel Pharmaceuticals Inc stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Rigel Pharmaceuticals Inc dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Learning More Rigel Pharmaceuticals Inc Dividends
You can contact us any time if you would like to ask questions about Rigel Pharmaceuticals Inc dividends or anything else related to the stock market.